Free Trial
NASDAQ:CLMT

Calumet (CLMT) Stock Price, News & Analysis

Calumet logo
$18.95 +0.12 (+0.64%)
Closing price 10/16/2025 04:00 PM Eastern
Extended Trading
$18.96 +0.02 (+0.08%)
As of 10/16/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Calumet Stock (NASDAQ:CLMT)

Advanced

Key Stats

Today's Range
$18.33
$19.31
50-Day Range
$13.23
$19.26
52-Week Range
$7.68
$25.29
Volume
671,652 shs
Average Volume
720,683 shs
Market Capitalization
$1.64 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.71
Consensus Rating
Hold

Company Overview

Calumet Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
12th Percentile Overall Score

CLMT MarketRank™: 

Calumet scored higher than 12% of companies evaluated by MarketBeat, and ranked 256th out of 270 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Calumet has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 4 buy ratings, 2 hold ratings, and 2 sell ratings.

  • Upside/Downside

    The consensus price target for Calumet is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Calumet has only been the subject of 3 research reports in the past 90 days.

  • Read more about Calumet's stock forecast and price target.
  • Earnings Growth

    Earnings for Calumet are expected to grow in the coming year, from ($3.02) to $0.15 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Calumet is -3.63, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Calumet is -3.63, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Calumet's valuation and earnings.
  • Percentage of Shares Shorted

    12.67% of the float of Calumet has been sold short.
  • Short Interest Ratio / Days to Cover

    Calumet has a short interest ratio ("days to cover") of 10.4, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Calumet has recently decreased by 5.86%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Calumet does not currently pay a dividend.

  • Dividend Growth

    Calumet does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    12.67% of the float of Calumet has been sold short.
  • Short Interest Ratio / Days to Cover

    Calumet has a short interest ratio ("days to cover") of 10.4, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Calumet has recently decreased by 5.86%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Calumet has a news sentiment score of 0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.67 average news sentiment score of Energy companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Calumet this week, compared to 4 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Calumet insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.07% of the stock of Calumet is held by insiders.

  • Percentage Held by Institutions

    Only 34.41% of the stock of Calumet is held by institutions.

  • Read more about Calumet's insider trading history.
Receive CLMT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Calumet and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CLMT Stock News Headlines

Calumet Inc.
Calumet Sees IBD RS Rating Rise To 77
The 7 Warning Signals Flashing Red Right Now
A free report revealing the 7 key indicators that have predicted every major economic collapse since 1929. Right now, all seven are flashing red simultaneously for the first time since 2007. These aren't the signals you'll see on CNBC.tc pixel
Calumet, Inc. (CLMT): A Bull Case Theory 
See More Headlines

CLMT Stock Analysis - Frequently Asked Questions

Calumet's stock was trading at $22.02 at the beginning of the year. Since then, CLMT shares have decreased by 13.9% and is now trading at $18.95.

Calumet, Inc. (NASDAQ:CLMT) issued its earnings results on Friday, August, 8th. The oil and gas company reported ($1.70) earnings per share for the quarter, missing the consensus estimate of ($0.44) by $1.26. The firm's revenue was down 9.4% compared to the same quarter last year.
Read the conference call transcript
.

Calumet subsidiaries include Biosynthetic Technologies, Specialty Oil Field Solutions, Anchor Drilling Fluids USA, United Petroleum Company, Bel-Ray, Montana Renewables, Royal Purple, and others.

Calumet's top institutional shareholders include O Keefe Stevens Advisory Inc. (0.03%) and Voya Investment Management LLC (0.01%). Insiders that own company stock include Jennifer Straumins, James S Carter, Stephen P Mawer, Scott Obermeier, Daniel J Sajkowski, Gregory J Morical, Ryan Willman and David Lunin.
View institutional ownership trends
.

Shares of CLMT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Calumet investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Two Harbors Investments (TWO), BlackRock Capital Investment (BKCC), NovoCure (NVCR), Viper Energy (VNOM) and Summit Midstream Partners (SMLP).

Company Calendar

Last Earnings
8/08/2025
Today
10/16/2025
Next Earnings (Estimated)
11/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Energy
Industry
OIL - US INTEGRTD
Sub-Industry
Petroleum And Natural Gas
Current Symbol
NASDAQ:CLMT
CIK
1340122
Employees
1,620
Year Founded
1916

Price Target and Rating

High Price Target
$33.00
Low Price Target
$13.25
Potential Upside/Downside
-1.3%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
($5.22)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$222 million
Net Margins
-11.09%
Pretax Margin
-11.07%
Return on Equity
N/A
Return on Assets
-12.65%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.76
Quick Ratio
0.45

Sales & Book Value

Annual Sales
$4.19 billion
Price / Sales
0.39
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($8.28) per share
Price / Book
-2.29

Miscellaneous

Outstanding Shares
86,750,000
Free Float
83,221,000
Market Cap
$1.64 billion
Optionable
Optionable
Beta
0.98

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:CLMT) was last updated on 10/17/2025 by MarketBeat.com Staff
From Our Partners